A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Clinical trial NCT06884618 · RECRUITING
Trial details
- NCT number
- NCT06884618
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2028-08-31
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.